In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximabDjordje Atanackovic, Tim Luetkens, Douglas W. Sborov et al.|Leukemia|2019Cited by 37
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myelomaSara Yousef, Djordje Atanackovic, Magdalena Kovacsovics‐Bankowski et al.|Human Vaccines & Immunotherapeutics|2015Cited by 33
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in Multiple MyelomaSara Yousef, Djordje Atanackovic, Tim Luetkens et al.|Clinical Lymphoma Myeloma & Leukemia|2015Cited by 1